What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- COPD
The scientist’s investigation covers issues in COPD, Internal medicine, Physical therapy, Spirometry and Exacerbation.
Jørgen Vestbo mostly deals with Obstructive lung disease in his studies of COPD.
He combines subjects such as Placebo and Surgery with his study of Internal medicine.
The study incorporates disciplines such as Smoking cessation, Cohort study, Disease, Severity of illness and Comorbidity in addition to Physical therapy.
Jørgen Vestbo has included themes like C-reactive protein, Pulmonary function testing, Bronchiectasis and Cardiology in his Spirometry study.
His Exacerbation research includes elements of Bronchodilator and Pediatrics.
His most cited work include:
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (14328 citations)
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper (3605 citations)
- Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. (2577 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in COPD, Internal medicine, Physical therapy, Intensive care medicine and Pulmonary disease.
His COPD study incorporates themes from Exacerbation, Spirometry, Asthma, Severity of illness and Cohort.
The Spirometry study combines topics in areas such as Pulmonary function testing and FEV1/FVC ratio.
His work in Internal medicine addresses subjects such as Surgery, which are connected to disciplines such as Respiratory disease.
Jørgen Vestbo interconnects Epidemiology, Population study, Obstructive lung disease, Disease and Comorbidity in the investigation of issues within Physical therapy.
His study in Fluticasone propionate is interdisciplinary in nature, drawing from both Placebo and Salmeterol.
He most often published in these fields:
- COPD (83.37%)
- Internal medicine (65.41%)
- Physical therapy (29.60%)
What were the highlights of his more recent work (between 2017-2021)?
- COPD (83.37%)
- Internal medicine (65.41%)
- Intensive care medicine (21.84%)
In recent papers he was focusing on the following fields of study:
Jørgen Vestbo spends much of his time researching COPD, Internal medicine, Intensive care medicine, Pulmonary disease and Exacerbation.
His COPD study focuses on Obstructive lung disease in particular.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Cardiology.
His study looks at the intersection of Intensive care medicine and topics like Clinical trial with Coronavirus disease 2019.
Within one scientific family, Jørgen Vestbo focuses on topics pertaining to Pharmacotherapy under Pulmonary disease, and may sometimes address concerns connected to Inhalation.
Jørgen Vestbo has researched Exacerbation in several fields, including Pneumonia, Prednisolone, Rate ratio, Respiratory system and Indacaterol.
Between 2017 and 2021, his most popular works were:
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 (472 citations)
- Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial. (238 citations)
- Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations (91 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
His primary areas of investigation include COPD, Internal medicine, Pulmonary disease, Exacerbation and Asthma.
Jørgen Vestbo does research in COPD, focusing on Obstructive lung disease specifically.
His work in the fields of Randomized controlled trial, FEV1/FVC ratio and Pneumonia overlaps with other areas such as In patient.
His Pulmonary disease research includes themes of Inhaled corticosteroids, Disease progression and Cigarette smoking.
The Exacerbation study which covers Gastroenterology that intersects with Risk of mortality, Fibrinogen, Confounding, Indacaterol and Beclometasone dipropionate.
His work carried out in the field of Asthma brings together such families of science as Respiratory disease, Genome-wide association study, Allergy and Environmental health.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
